Article: King Pharmaceuticals Reports Efficacy of ALTACE(R) 20mg And Efficacy of a Combination of ALTACE 20mg And Hydrochlorothiazide 25mg For 24-hour Blood Pressure Control.

BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE:KG) reported today that data from its Phase III clinical trial evaluating ALTACE([R]) (ramipril) 20mg and the combination of ALTACE 20mg and hydrochlorothiazide (HCT) 25mg were presented this weekend at the American Society of Hypertension, Inc. (ASH) Twenty-Second Annual Scientific Meeting and Exposition (ASH 2007) in Chicago, Illinois. The clinical trial data showed that ALTACE 20mg resulted in significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP). ALTACE 20mg used in combination with HCT 25mg once daily as measured by a semi-automatic digital blood pressure device (office ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!